Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Dr Roberto Amato from the Wellcome Trust Centre for Human Genetics is interviewed about a recent MalariaGEN study about the genetics underlying resistance to the antimalarial artemisinin.